|
1993. 11. 19 |
´ëÇѼÒȱâÇÐȸ Çмú»ó : À¯Àü¼º ºñ¿ëÁ¾Áõ ´ëÀå¾ÏÀÇ Ä¡·á |
1997. 6. 26 |
¹Ì±¹´ëÀå¿Ü°úÇÐȸ Çмú»ó : ¡ºGermline mutations of hMLH1 and hMSH2 genes in suspected hereditary nonpolyposis colorectal cancer(HNPCC) and sporadic early- onset colorectal cancer patients¡» |
2001. 4. |
Çѱ¹°úÇÐÀç´ÜÁö¿ø ¿ì¼ö¿¬±¸¼º°ú 30¼± : ü³»¿Í ü¿Ü¿¡¼ÀÇ ÀÎüÁ¾¾ç¼¼Æ÷ : ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ 12Á¾ÀÇ ¼ö¸³ |
2001. 6. 20 |
´ëÇѹα¹ ȲÁ¶±ÙÁ¤ÈÆÀå |
2002. 5. 4 |
´ëÇÑÀÇ»çÇùȸ ¿ì¼öÇѱ¹ÀÎ ÀÇ°úÇÐÀÚ 20ÀÎ : À¯Àü¼º¾Ï |
2002. 11. 26 |
Çѱ¹´ã¹è¼ÒºñÀÚº¸È£Çùȸ Á¦4ȸ ´ã¹è¼ÒºñÀÚº¸È£´ë»ó ¼ÒºñÀÚº¸È£ºÎ¹® |
2002. 11. 30 |
´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ±¹Á¦ÇÐȸÁöÇмú»ó :¡ºMutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene¡» |
2003. 3. 11 |
Á¦2ȸ º¸·É¾ÏÇмú»ó |
2003. 6. 26 |
Àü±¹ ÀÇ»ç ±Ý¿¬ ¼±Æ÷½Ä: ´ëÇÑÀÇ»çÇùȸ °ø·ÎÆÐ |
2003. 7. 14 |
¼º°îÇмú¹®ÈÀç´Ü Á¦18ȸ ¼º°îÇмú¹®È»ó ÀÚ¿¬°úÇкι® |
2004. 1. 28 |
Á¦3ȸ ¼¿ï´ëÇб³ AMP(Advancecd Management Program) ´ë»ó |
2004. 4. 21 |
¼¿ï´ëÇб³º´¿ø 2003³âµµ SCI I.F ÃÖ¿ì¼ö»ó |
2004. 4. 21 |
¼¿ï´ëÇб³º´¿ø 2003³âµµ SCI ÀúÀÛ¿ì¼ö»ó |
2004. 12. 1 |
Á¦4ȸ ÀÚ¶û½º·± Çѱ¹ÀÎ ´ë»ó (Çѱ¹ ¾ð·ÐÀÎ ¿¬ÇÕȸ) |
2005. 5. 18 |
¼¿ï´ëÇб³º´¿ø 2004³âµµ SCI I.F ¿ì¼ö»ó |
2005. 5. 18 |
¼¿ï´ëÇб³º´¿ø 2004³âµµ SCI ÀúÀÛ¿ì¼ö»ó |
2005. 5. 31 |
2005 ¼¼°è±Ý¿¬Àdz¯ WHO ±Ý¿¬°ø·Î»ó |
|
1987 |
Characteristics of cell lines established from human colorectal carcinoma. |
1988 |
Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. |
1990 |
Characteristics of cell lines established from human gastric carcinoma. |
1993 |
Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. |
1995 |
Characterization of cell lines established from human hepatocellular carcinoma. |
1996 |
Germline mutations of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. |
1997 |
Establishment and characterization of human gastric carcinoma cell lines. |
1997 |
Establishment and characterization of 12 uterine cervical-carcinoma cell lines : Common sequence variation in the E7 gene of HPV-16-positive cell lines. |
1997 |
Establishment and characterization of human ovarian carcinoma cell lines. |
1999 |
Establishment and characterization of human laryngeal carcinoma cell lines. |
2000 |
E-cadherin gene promoter methylation as the second genetic hit in hereditary gastric cancer. |
2000 |
Report on the first meeting of the International Collaborative Group on Herediatry Gastric Cancer. |
2002 |
RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes. |
2002 |
Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene. |
2003 |
A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer. |
2004 |
Germline mutations in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families. |
2004 |
Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. |
2005 |
Down-regulation of Mitochondria F1F0-ATP Synthase in Human Colon Cancer Cells with Induced 5-Fluorouracil Resistance. |